These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 20084990

  • 1. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C.
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [Abstract] [Full Text] [Related]

  • 2. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A, Jamil M, Rahman MAU, Mustafa T.
    BMC Infect Dis; 2019 Oct 30; 19(1):923. PubMed ID: 31666021
    [Abstract] [Full Text] [Related]

  • 3. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ, Feng JY, Chiu YC, Huang SF, Lee YC.
    Eur Respir J; 2011 Feb 30; 37(2):376-83. PubMed ID: 20516049
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 30; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 30; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 6. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon.
    Djouma FN, Noubom M, Ateudjieu J, Donfack H.
    BMC Infect Dis; 2015 Mar 21; 15():139. PubMed ID: 25884844
    [Abstract] [Full Text] [Related]

  • 7. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study.
    Pefura-Yone EW, Kengne AP, Kuaban C.
    BMC Infect Dis; 2014 Mar 11; 14():138. PubMed ID: 24618155
    [Abstract] [Full Text] [Related]

  • 8. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S, Kumar A, Kapoor SK.
    Indian J Tuberc; 2012 Jul 11; 59(3):135-40. PubMed ID: 23362709
    [Abstract] [Full Text] [Related]

  • 9. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
    Harries AD, Gausi F, Chimzizi R, Salaniponi FM.
    Int J Tuberc Lung Dis; 2004 Mar 11; 8(3):384-7. PubMed ID: 15139479
    [Abstract] [Full Text] [Related]

  • 10. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
    Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D, Tilley P.
    Infect Control Hosp Epidemiol; 2003 Nov 11; 24(11):831-8. PubMed ID: 14649771
    [Abstract] [Full Text] [Related]

  • 11. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D, Bechan S, Connolly C, Standing E, Short GM.
    Int J Tuberc Lung Dis; 1998 Jan 11; 2(1):52-5. PubMed ID: 9562111
    [Abstract] [Full Text] [Related]

  • 12. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH, Elewa H, Alkabab Y, Nazer LH, Heysell SK.
    BMC Infect Dis; 2018 Aug 08; 18(1):384. PubMed ID: 30089476
    [Abstract] [Full Text] [Related]

  • 13. The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
    Morris CD.
    S Afr Med J; 1996 Aug 08; 86(8):958-60. PubMed ID: 8823422
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A.
    BMC Infect Dis; 2016 Aug 02; 16():365. PubMed ID: 27484399
    [Abstract] [Full Text] [Related]

  • 15. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F, Mahan CS.
    Int J Tuberc Lung Dis; 2012 Dec 02; 16(12):1663-7. PubMed ID: 23131266
    [Abstract] [Full Text] [Related]

  • 16. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul 02; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 17. Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
    Chierakul N, Chaiprasert A, Tingtoy N, Arjratanakul W, Pattanakitsakul SN.
    Respirology; 2001 Dec 02; 6(4):305-9. PubMed ID: 11844121
    [Abstract] [Full Text] [Related]

  • 18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 02; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 19. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.
    J Assoc Physicians India; 2012 Aug 02; 60():22-6. PubMed ID: 23405517
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K, Spigt M, Dinant GJ.
    BMC Pulm Med; 2018 Feb 20; 18(1):37. PubMed ID: 29463234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.